Letters Risks of antithrombotic treatment after gastrointestinal bleeding in atrial fibrillation

Authors’ reply to Beales

BMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i266 (Published 20 January 2016) Cite this as: BMJ 2016;352:i266
  1. Laila Staerk, research fellow1,
  2. Gregory Y H Lip, professor2
  1. 1Department of Cardiology, Copenhagen University Hospital Herlev, and Gentofte, Kildegaardsvej 28, 2900 Hellerup, Denmark
  2. 2University of Birmingham Centre for Cardiovascular Sciences, Birmingham City Hospital, Birmingham UK
  1. Lailastaerk{at}gmail.com

We thank Beales for his comments about our paper.1 2

It is correct that current guidelines for atrial fibrillation do not include antiplatelet agents for stroke prophylaxis. However, we thought it important to examine all possible antithrombotic treatments after a gastrointestinal bleed to compare the effectiveness and safety of oral anticoagulation versus non-resumption or antiplatelet agents. The results suggested that independent of the antithrombotic treatment regimen used before the bleed, patients with atrial fibrillation benefited …

View Full Text

Log in

Log in through your institution


* For online subscription